Stock Events

Stock Events

Keros Therapeutics (KROS) Q3 2025 Earnings

6AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.41

0.27

1.94

3.62

Details

Expected EPS

-1.109809

Actual EPS

-0.76

Surprise EPS

0.35

Surprise Percent

+31.52%

Description

Keros Therapeutics (KROS) has reported earnings of -0.76 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.